IL58656A - Halogen substituted benzopyran and benzothiopyran-4-carboxylic acids and pharmaceutical compositions containing them - Google Patents

Halogen substituted benzopyran and benzothiopyran-4-carboxylic acids and pharmaceutical compositions containing them

Info

Publication number
IL58656A
IL58656A IL58656A IL5865679A IL58656A IL 58656 A IL58656 A IL 58656A IL 58656 A IL58656 A IL 58656A IL 5865679 A IL5865679 A IL 5865679A IL 58656 A IL58656 A IL 58656A
Authority
IL
Israel
Prior art keywords
benzothiopyran
pharmaceutical compositions
carboxylic acids
compositions containing
halogen substituted
Prior art date
Application number
IL58656A
Other languages
English (en)
Other versions
IL58656A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL58656A0 publication Critical patent/IL58656A0/xx
Publication of IL58656A publication Critical patent/IL58656A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/92Naphthopyrans; Hydrogenated naphthopyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL58656A 1978-11-08 1979-11-07 Halogen substituted benzopyran and benzothiopyran-4-carboxylic acids and pharmaceutical compositions containing them IL58656A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/959,023 US4210663A (en) 1978-11-08 1978-11-08 Halogen substituted benzopyran- and benzothiopyran-4-carboxylic acids

Publications (2)

Publication Number Publication Date
IL58656A0 IL58656A0 (en) 1980-02-29
IL58656A true IL58656A (en) 1983-06-15

Family

ID=25501572

Family Applications (1)

Application Number Title Priority Date Filing Date
IL58656A IL58656A (en) 1978-11-08 1979-11-07 Halogen substituted benzopyran and benzothiopyran-4-carboxylic acids and pharmaceutical compositions containing them

Country Status (16)

Country Link
US (1) US4210663A (xx)
EP (1) EP0011426B1 (xx)
JP (2) JPS6033433B2 (xx)
KR (1) KR830001821B1 (xx)
AR (1) AR223195A1 (xx)
AT (1) AT366680B (xx)
AU (1) AU513399B2 (xx)
CA (1) CA1132584A (xx)
DE (1) DE2965755D1 (xx)
DK (1) DK153947C (xx)
ES (1) ES485798A1 (xx)
FI (1) FI71139C (xx)
IE (1) IE49109B1 (xx)
IL (1) IL58656A (xx)
PT (1) PT70420A (xx)
YU (1) YU41675B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305955A (en) * 1980-10-21 1981-12-15 Pfizer Inc. Carboxylic acid therapeutic agents
US4486428A (en) * 1982-03-16 1984-12-04 Pfizer Inc. Bicyclic benzo fused compounds
US4537920A (en) * 1983-08-18 1985-08-27 Ethyl Corporation 4H-1-benzopyrans and lubricant compositions containing same
US4551542A (en) * 1984-09-26 1985-11-05 Pfizer Inc. Regeneration of 6-fluoro-4-chromanone from 6-fluoro-4-ureidochroman-4-carboxylic acid
HU206618B (en) * 1986-01-17 1992-12-28 Pfizer Process for producing hydroxyacetic acid derivatives for treating complications of diabetes and pharmaceutical compositions containing them
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
EP0541807B1 (en) * 1990-07-27 1997-12-17 Chugai Seiyaku Kabushiki Kaisha Novel benzopyran derivative
JP3255411B2 (ja) * 1991-02-18 2002-02-12 中外製薬株式会社 発毛促進剤
US5407897A (en) * 1993-03-03 1995-04-18 American Cyanamid Company Method for safening herbicides in crops using substituted benzopyran and tetrahydronaphthalene compounds
AU2440599A (en) * 1998-02-25 1999-09-15 Shionogi & Co., Ltd. Therapeutic agent for complication of diabetes
US7288279B2 (en) * 2001-12-21 2007-10-30 Michael Foods Of Delaware, Inc. Formulated fried egg product
JP4742215B2 (ja) * 2003-06-23 2011-08-10 Jnc株式会社 クロマン化合物、この化合物を含有する液晶組成物およびこの液晶組成物を含有する液晶表示素子
JP5956920B2 (ja) 2012-12-14 2016-07-27 株式会社コガネイ 液体供給装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications

Also Published As

Publication number Publication date
JPS5585582A (en) 1980-06-27
US4210663A (en) 1980-07-01
DK153947B (da) 1988-09-26
FI71139B (fi) 1986-08-14
IE49109B1 (en) 1985-08-07
EP0011426A1 (en) 1980-05-28
ES485798A1 (es) 1980-10-01
FI71139C (fi) 1986-11-24
JPS6033433B2 (ja) 1985-08-02
DK153947C (da) 1989-02-20
CA1132584A (en) 1982-09-28
IL58656A0 (en) 1980-02-29
EP0011426B1 (en) 1983-06-22
KR830001273A (ko) 1983-04-30
IE792136L (en) 1980-05-08
FI793487A (fi) 1980-05-09
AU5258279A (en) 1980-05-15
YU41675B (en) 1987-12-31
KR830001821B1 (ko) 1983-09-12
JPS56103176A (en) 1981-08-18
AU513399B2 (en) 1980-11-27
ATA719279A (de) 1981-09-15
PT70420A (de) 1979-12-01
AR223195A1 (es) 1981-07-31
JPS6113716B2 (xx) 1986-04-15
DE2965755D1 (en) 1983-07-28
DK471079A (da) 1980-05-09
AT366680B (de) 1982-04-26
YU269779A (en) 1983-02-28

Similar Documents

Publication Publication Date Title
DE2961979D1 (en) Novel naphtyridine derivatives and pharmaceutical compositions containing them
NZ189378A (en) 4-amino-5-alkylsulphonyl-ortho-anisamdes and pharmaceutical compositions
IL56992A0 (en) N-heterocyclyl-4-piperidinamines their preparation and pharmaceutical compositions containing them
NZ190784A (en) Benzofuranyl-piperidines and pharmaceutical compositions
IL56407A (en) 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them
IL58656A (en) Halogen substituted benzopyran and benzothiopyran-4-carboxylic acids and pharmaceutical compositions containing them
IL57040A0 (en) Mercaptoimidazole derivatives their preparation and pharmaceutical compositions containing them
NZ189684A (en) Substituted 2-phenylimino-imidazolidines pharmaceutical compositions
IL56577A0 (en) Pharmaceutical compositions comprising certain pyrrolidinederivatives
IL57268A0 (en) Di-o-n-alkyl clycerol derivatives and pharmaceutical compositions containing them
IL58415A0 (en) Phenyl-quinolizidines their manufacture and pharmaceutical compositions containing them
NZ190521A (en) Phenylamino-thiophenacetic acids and pharmaceutical compositions
NZ190810A (en) 1-aminoalkyl-3-phenoxy-propan-2-ol derivatives pharmaceutical compositions
NZ189626A (en) Halogen substituted mercaptoacylimino acids pharmaceutical compositions
IL58621A0 (en) Pharmaceutical compositions comprising aryltrifluoroethanol derivatives
NZ189899A (en) Dilignols and dilignol-type compounds pharmaceutical compositions
GB2031727B (en) Pharmaceutical compositions
GB2039218B (en) Pharmaceutical compositions
NZ189279A (en) Arylaminoimidazolines and pharmaceutical compositions
NZ190293A (en) Benzimidoyl-piperazines and pharmaceutical compositions
IL57882A0 (en) 2-thiophenecarboxamido-alkylmercaptans and pharmaceutical compositions containing them
NZ190007A (en) Steroid-spiro-oxazolidinone derivatives and pharmaceutical compositions
NZ190665A (en) S-benzylcysteine derivatives and pharmaceutical compositions
IL58169A0 (en) -alkyl-o-oxybenzylamine derivatives their preparation and pharmaceutical compositions containing them
NZ189856A (en) 6-azido-decahydro-isoquinolines and pharmaceutical compositions